share_log

4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Dogan Timur

4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Dogan Timur

4/A:持股變動聲明(修正)-高管 Dogan Timur
美股SEC公告 ·  2024/09/24 04:29

Moomoo AI 已提取核心訊息

Cardio Diagnostics Holdings, Inc. (CDIO.US) reported that its Chief Technology Officer, Dogan Timur, completed a purchase of company stock on September 6, 2024. The transaction involved the acquisition of 68,965 shares of common stock at a price of $0.29 per share. Following this transaction, Timur's direct holdings in the company increased to a total of 197,310 shares. The transaction is part of an open market or private purchase, as per the announcement.
Cardio Diagnostics Holdings, Inc. (CDIO.US) reported that its Chief Technology Officer, Dogan Timur, completed a purchase of company stock on September 6, 2024. The transaction involved the acquisition of 68,965 shares of common stock at a price of $0.29 per share. Following this transaction, Timur's direct holdings in the company increased to a total of 197,310 shares. The transaction is part of an open market or private purchase, as per the announcement.
Cardio診斷控股有限公司(CDIO.US)報告稱,其首席技術官多安·提默爾於2024年9月6日完成了對公司股票的購買。交易涉及以每股0.29美元的價格收購69,965股普通股。在此交易之後,提默爾在公司的直接持股總數增加至197,310股。根據公告,此交易屬於公開市場或私人購買的一部分。
Cardio診斷控股有限公司(CDIO.US)報告稱,其首席技術官多安·提默爾於2024年9月6日完成了對公司股票的購買。交易涉及以每股0.29美元的價格收購69,965股普通股。在此交易之後,提默爾在公司的直接持股總數增加至197,310股。根據公告,此交易屬於公開市場或私人購買的一部分。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息